Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析

◆英語タイトル:Ampio Pharmaceuticals Inc (AMPE) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15092
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥39,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥79,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥119,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ampio Pharmaceuticals Inc (Ampio), formerly Chay Enterprises Inc is a biopharmaceutical company that discovers and develops novel therapeutic candidates for inflammatory conditions. The company develops compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level. It provides products for the treatment of osteoarthritis, diabetic macular edema, and other prevalent, inflammatory diseases. Ampio’s products include low molecular weight fraction of human serum albumin and ultra-low dose of danazol. Its ultra-low dose of danazol is used for the oral treatment of diabetic macular edema. The company conducts research on various future indications for optina. It partners with other biopharmaceutical companies for its research activities. Ampio is headquartered in Englewood, Colorado, the US.

Ampio Pharmaceuticals Inc Key Recent Developments

Sep 12,2018: Ampio Reports Manuscript on the Mechanisms of Action (MOA) for Ampion™ accepted for Publication in “Clinical and Experimental Rheumatology™”
May 14,2018: Ampio Provides Corporate Update
Mar 15,2018: Ampio Pharmaceuticals Provides Corporate Update Following Conference Call

This comprehensive SWOT profile of Ampio Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ampio Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ampio Pharmaceuticals Inc – Key Information
Ampio Pharmaceuticals Inc – Overview
Ampio Pharmaceuticals Inc – Key Employees
Ampio Pharmaceuticals Inc – Key Employee Biographies
Ampio Pharmaceuticals Inc – Key Operational Heads
Ampio Pharmaceuticals Inc – Major Products and Services
Ampio Pharmaceuticals Inc – History
Ampio Pharmaceuticals Inc – Company Statement
Ampio Pharmaceuticals Inc – Locations And Subsidiaries
Ampio Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ampio Pharmaceuticals Inc – Business Description
Ampio Pharmaceuticals Inc – Corporate Strategy
Ampio Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Ampio Pharmaceuticals Inc – Strengths
Ampio Pharmaceuticals Inc – Weaknesses
Ampio Pharmaceuticals Inc – Opportunities
Ampio Pharmaceuticals Inc – Threats
Ampio Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Ampio Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ampio Pharmaceuticals Inc, Key Information
Ampio Pharmaceuticals Inc, Key Ratios
Ampio Pharmaceuticals Inc, Share Data
Ampio Pharmaceuticals Inc, Major Products and Services
Ampio Pharmaceuticals Inc, History
Ampio Pharmaceuticals Inc, Key Employees
Ampio Pharmaceuticals Inc, Key Employee Biographies
Ampio Pharmaceuticals Inc, Key Operational Heads
Ampio Pharmaceuticals Inc, Other Locations
Ampio Pharmaceuticals Inc, Subsidiaries
Ampio Pharmaceuticals Inc, Key Manufacturing facilities
Ampio Pharmaceuticals Inc, Key Competitors
Ampio Pharmaceuticals Inc, SWOT Analysis
Ampio Pharmaceuticals Inc, Ratios based on current share price
Ampio Pharmaceuticals Inc, Annual Ratios
Ampio Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Ampio Pharmaceuticals Inc, Performance Chart
Ampio Pharmaceuticals Inc, Ratio Charts

★海外企業調査レポート[Ampio Pharmaceuticals Inc (AMPE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ability Pharmaceuticals SL:製薬・医療:M&Aディール及び事業提携情報
    Summary Ability Pharmaceuticals SL (Ability Pharma), formerly AB Therapeutics SL is a biopharmaceutical company that discovers and develops human therapeutics for the treatment of cancer and other indications. The company’s lead pipeline drug candidate includes ABTL0812, a new drug class of small mo …
  • Axion Power International Inc (AXPW):企業の財務・戦略的SWOT分析
    Summary Axion Power International Inc (Axion Power) is an energy equipment manufacturer that manufactures, develops, designs, and sells energy storage components, equipment, and devices. The company's products include batteries, energy storage equipment, advanced energy storage products, PowerCube m …
  • True Diagnostics Inc:製品パイプライン分析
    Summary True Diagnostics Inc (True Diagnostics) is a research, development and manufacturing company that offers in-vitro immunodiagnostic test systems and reagents. The company provides trueDX platform technology including trueDX reader, trueDX software, trueDX-TSH test, trueDX-T4 test, trueDX-Gneg …
  • S.A.G. Solar GmbH & Co KG:電力:M&Aディール及び事業提携情報
    Summary S.A.G. Solar GmbH & Co. KG. (S.A.G. Solar) a subsidiary of Shunfeng International Clean Energy Limited, is a manufacturer of photovoltaic systems. The company constructs, installs, operates and integrates solar power plants. It constructs rooftop systems, roof and facade-integrated systems, …
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Cabot Corp (CBT):企業の財務・戦略的SWOT分析
    Cabot Corp (CBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Zara Investment (Holding) Co Ltd:企業の戦略・SWOT・財務情報
    Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Zara Investment (Holding) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • CMA CGM SA:戦略・SWOT・企業財務分析
    CMA CGM SA - Strategy, SWOT and Corporate Finance Report Summary CMA CGM SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Immunodiagnostic Systems Holdings plc (IDH):医療機器:M&Aディール及び事業提携情報
    Summary Immunodiagnostic Systems Holdings plc (IDS) is an in-vitro diagnostic solution provider that develops, manufactures and markets immunoassays and automated immunoanalyser technologies. The company conducts research in the areas of bone turnover market, animal research, and other research area …
  • Solvang ASA (SOLV):企業の財務・戦略的SWOT分析
    Summary Solvang ASA (Solvang) is an oil and gas company that offers LPG and petrochemical gases transportation services. The company operates through its business areas such as semi-refrigerated or ethylene carriers, LGC, and panamax and VLGC. Its semi-refrigerated or ethylene carriers business area …
  • UPM-Kymmene Corporation (UPM):企業の財務・戦略的SWOT分析
    UPM-Kymmene Corporation (UPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Logitech International S.A.:企業の戦略・SWOT・財務情報
    Logitech International S.A. - Strategy, SWOT and Corporate Finance Report Summary Logitech International S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Power Grid Corporation of India Limited:企業の戦略・SWOT・財務分析
    Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report Summary Power Grid Corporation of India Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Shanghai Electric Group Co Ltd:企業のM&A・事業提携・投資動向
    Shanghai Electric Group Co Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Shanghai Electric Group Co Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers a …
  • ImmunoGen Inc (IMGN):企業の財務・戦略的SWOT分析
    ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • CITGO Petroleum Corporation:企業の戦略・SWOT・財務情報
    CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report Summary CITGO Petroleum Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China Life Insurance Co Ltd:戦略・SWOT・企業財務分析
    China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Life Insurance Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Allen-Vanguard Corp:企業の戦略・SWOT・財務分析
    Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report Summary Allen-Vanguard Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆